[Studies on the therapy of hyperlipemic athersclerosis and liver epithelial fatty degeneration with beta-pyridylcarbinol].
D000368:Aged; D000435:Alcoholic Intoxication / Q000188:drug therapy; D000818:Animals; D001161:Arteriosclerosis / Q000188:drug therapy*; D002784:Cholesterol / Q000097:blood; D005227:Fatty Acids / Q000097:blood; D005234:Fatty Liver / Q000188:drug therapy*; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy*; D008875:Middle Aged; D009539:Nicotinic Acids / Q000627:therapeutic use; D011725:Pyridines / Q000627:therapeutic use*; D051381:Rats; D014665:Vasodilator Agents / Q000627:therapeutic use*
D005227:Fatty Acids; D009539:Nicotinic Acids; D011725:Pyridines; D014665:Vasodilator Agents; D002784:Cholesterol
Untersuchungen über die Behandlung der hyperlipämischen Atherosklerose und der Leberepithelverfettung mit beta-Pyridylcarbinol.